VBP15-003: A Phase II Open-label, Multicenter Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys with Duchenne Muscular Dystrophy (DMD)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/9/169/30/19

Funding

  • Reveragen Biopharma, Inc.